Genomic DNA was extracted using the
QIAamp PowerFecal Pro DNA Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s instructions from fecal samples, which were collected using a stool collection kit containing guanidine (TechnoSuruga Laboratory, Shizuoka, Japan) and stored at −80°C until analysis. Metagenome analysis was performed on a next-generation sequencer (
MySeq: Illumina, San Diego, California, USA) to analyze the 16S V3 and V4 regions of ribosomal RNA genes. Quiime2 (
https://qiime2.org/) was used to identify bacteria.
Masuda J., Sakai H., Tsurutani J., Tanabe Y., Masuda N., Iwasa T., Takahashi M., Futamura M., Matsumoto K., Aogi K., Iwata H., Hosonaga M., Mukohara T., Yoshimura K., Imamura C.K., Miura S., Yamochi T., Kawabata H., Yasojima H., Tomioka N., Yoshimura K, & Takano T. (2023). Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial). Journal for Immunotherapy of Cancer, 11(9), e007126.